Former President Joe Biden’s diagnosis with an aggressive form of prostate cancer has put a spotlight on prostate cancer ...

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

New findings suggest that a PSA level of 0.2 ng/mL or greater can predict a poor prognosis and indicate a possible need for ...

The multimodal ArteraAI Prostate Test combines digital images of patients' biopsies and clinical data to predict prognoses and treatment outcomes.

We are making significant progress in reducing the cancer burden in the U.S. Today, research from the American Cancer Society ...

A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor ...

Genetics and poor healthcare contribute to Black men's prostate cancer disparities. Unequal care, not biology, is the root ...

The Florida Cancer Specialists & Research Institute (FCS) has introduced a liquid biopsy test to identify circulating cells ...

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.